胰腺癌的放化疗
Chemoradiotherapy in pancreatic carcinoma.
作者信息
Pathy Sushmita, Chander Subhash
机构信息
Department of Radiation Oncology, All India Institute Of Medical Sciences, Ansari Nagar, New Delhi - 110 029, India.
出版信息
Indian J Med Paediatr Oncol. 2009 Apr;30(2):55-60. doi: 10.4103/0971-5851.60049.
Abstract
Pancreatic cancer patients present late in their course and surgical resection as a modality of treatment is of limited value. Majority develop loco-regional failure and distant metastasis, therefore, adjuvant therapy comprising of radiotherapy and chemotherapy are useful treatment options to achieve higher loco-regional control. Specialized irradiation techniques like intra-operative radiotherapy that help to increase the total tumor dose have been used, however, controvertible survival benefit was observed. Various studies have shown improved median and overall survival with chemoradiotherapy for advanced unresectable pancreatic carcinoma. The role of new agents such as topoisomerase I inhibitors also needs further clinical investigations.
摘要
胰腺癌患者就诊时病情往往已处于晚期，手术切除作为一种治疗方式，其价值有限。大多数患者会出现局部区域复发和远处转移，因此，包括放疗和化疗的辅助治疗是实现更高局部区域控制的有效治疗选择。已采用如术中放疗等有助于增加肿瘤总剂量的特殊照射技术，然而，观察到的生存获益存在争议。多项研究表明，对于晚期不可切除的胰腺癌，放化疗可改善中位生存期和总生存期。拓扑异构酶I抑制剂等新型药物的作用也需要进一步的临床研究。
相似文献
1
Chemoradiotherapy in pancreatic carcinoma.胰腺癌的放化疗
Indian J Med Paediatr Oncol. 2009 Apr;30(2):55-60. doi: 10.4103/0971-5851.60049.
2
[Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].[125例局部晚期头颈部鳞状细胞癌多模态治疗的疗效及预后因素]
Zhonghua Zhong Liu Za Zhi. 2014 Mar;36(3):217-22.
3
Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer.局部晚期胰腺癌的术前化疗、放疗及手术切除
Arch Surg. 2000 Jan;135(1):81-7; discussion 88. doi: 10.1001/archsurg.135.1.81.
4
Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.胰腺和十二指肠腺癌的术前放化疗
Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):161-7. doi: 10.1016/0360-3016(94)90531-2.
5
[Adjuvant chemotherapy (nedaplatin/UFT) after concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma].局部晚期头颈部鳞状细胞癌同步放化疗后辅助化疗（奈达铂/替加氟尿嘧啶）
Nihon Jibiinkoka Gakkai Kaiho. 2006 Mar 20;109(3):149-56. doi: 10.3950/jibiinkoka.109.149.
6
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.术前超分割放化疗用于既往盆腔放疗后的局部复发性直肠癌患者：一项多中心II期研究。
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18.
7
Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.同步放化疗后行食管癌切除术可改善临床II期或III期食管癌患者的局部区域控制。
Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1484-93. doi: 10.1016/j.ijrobp.2004.05.056.
8
Concurrent Chemoradiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma: Treatment Outcomes and Prognostic Factors.局部晚期鼻咽癌同步放化疗：治疗结果与预后因素
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1591-1599. doi: 10.22034/APJCP.2018.19.6.1591.
9
Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer.术前放化疗后进行手术切除对部分无法切除的胰腺癌患者有益。
Am J Clin Oncol. 2003 Feb;26(1):30-6. doi: 10.1097/00000421-200302000-00007.
10
Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer.局部晚期非炎性乳腺癌联合化疗及术前放疗后进行保守局部治疗的可能性
Int J Radiat Oncol Biol Phys. 1996 Mar 15;34(5):1019-28. doi: 10.1016/0360-3016(95)02207-4.
引用本文的文献
1
Pancreatic adenocarcinoma: A review of recent paradigms and advances in epidemiology, clinical diagnosis and management.胰腺导管腺癌：流行病学、临床诊断和治疗的最新模式和进展综述。
World J Gastroenterol. 2021 Jun 21;27(23):3158-3181. doi: 10.3748/wjg.v27.i23.3158.
本文引用的文献
1
Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer.依喜替康与吉西他滨联合用药对比吉西他滨单药治疗未经治疗的晚期胰腺癌的随机III期研究。
J Clin Oncol. 2006 Sep 20;24(27):4441-7. doi: 10.1200/JCO.2006.07.0201.
2
Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.局部晚期导管腺癌放化疗后的胰腺切除术：围手术期结局与生存分析
Ann Surg Oncol. 2006 Sep;13(9):1201-8. doi: 10.1245/s10434-006-9032-x. Epub 2006 Sep 6.
3
Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.吉西他滨联合顺铂与单纯吉西他滨治疗晚期胰腺癌的随机III期试验
J Clin Oncol. 2006 Aug 20;24(24):3946-52. doi: 10.1200/JCO.2005.05.1490.
4
Pancreatic cancer: from bench to 5-year survival.胰腺癌：从实验室到5年生存率
Pancreas. 2006 Aug;33(2):111-8. doi: 10.1097/01.mpa.0000229010.62538.f2.
5
Phase I/II trial of hyperfractionated accelerated chemoradiotherapy for unresectable advanced pancreatic cancer.不可切除的晚期胰腺癌超分割加速放化疗的I/II期试验。
Jpn J Clin Oncol. 2006 Aug;36(8):504-10. doi: 10.1093/jjco/hyl064. Epub 2006 Jul 19.
6
ERT following IORT improves survival of patients with resectable pancreatic cancer.术中放疗后行体外放疗可提高可切除胰腺癌患者的生存率。
Hepatogastroenterology. 2005 Jul-Aug;52(64):1244-9.
7
Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.胰头和壶腹周围腺癌手术切除及术中放疗后的生存率。
Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1060-6. doi: 10.1016/j.ijrobp.2005.03.036. Epub 2005 Jun 22.
8
Synergistic effects of interferon-alpha in combination with chemoradiation on human pancreatic adenocarcinoma.α-干扰素联合放化疗对人胰腺腺癌的协同作用
World J Gastroenterol. 2005 Mar 14;11(10):1521-8. doi: 10.3748/wjg.v11.i10.1521.
9
Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate.与吉西他滨单药治疗相比，伊立替康联合吉西他滨治疗局部晚期或转移性胰腺癌患者时，尽管肿瘤缓解率有所提高，但并未带来生存获益。
J Clin Oncol. 2004 Sep 15;22(18):3776-83. doi: 10.1200/JCO.2004.12.082.
10
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.胰腺癌切除术后放化疗与单纯化疗的随机试验。
N Engl J Med. 2004 Mar 18;350(12):1200-10. doi: 10.1056/NEJMoa032295.
Zotero 插件